Position in GRAL
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$94,884
-$62,259 QoQ
Shares Held
1,836
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Wellington Shields Capital Management, LLC holds $4,858,326 across 7 Diagnostics & Research names. GRAL ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PSNL |
Personalis, Inc.
|
339,733 | $2,164,099 | |
| 2 | ILMN |
Illumina, Inc.
|
10,140 | $1,249,856 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
1,442 | $708,786 | |
| 4 | WAT |
Waters Corp /De/
|
1,049 | $312,392 | |
| 5 | RVTY |
Revvity, Inc.
|
3,300 | $289,113 | |
| 6 | GRAL |
GRAIL, Inc.
This page
|
1,836 | $94,884 | |
| 7 | DGX |
Quest Diagnostics Inc
|
200 | $39,196 |
All Filings in GRAL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $94,884 | 1,836 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $157,143 | 1,836 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $108,562 | 1,836 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $96,978 | 1,886 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $48,168 | 1,886 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $32,968 | 1,847 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $39,174 | 2,847 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||